Gardasil
Recombinant quadrivalent HPV vaccine · Merck Sharp & Dohme (MSD)
Prevents
Dosing schedules
Females aged 9–13: 2 doses (0, 6 months or 0, 12 months)
For: Adolescents (9–17 years)
| Dose | Age | Minimum interval from previous dose |
|---|---|---|
| Dose 1 (Gardasil) | 9 years | – |
| Dose 2 (Gardasil) | 6 or 12 months after dose 1 | 180 days |
Source: Recommended vaccination schedules for all ages in Vietnam (2026 edition). Reviewed on 07/10/2026.
Females aged 9–26: 3 doses (0, 2, 6 months)
For: Adolescents (9–17 years)
| Dose | Age | Minimum interval from previous dose |
|---|---|---|
| Dose 1 (Gardasil) | 9 years | – |
| Dose 2 (Gardasil) | 2 months after dose 1 (at least 1 month) | 28 days |
| Dose 3 (Gardasil) | 6 months after dose 1 (at least 3 months after dose 2) | 90 days |
Source: Recommended vaccination schedules for all ages in Vietnam (2026 edition). Reviewed on 07/10/2026.
Special precautions
Indicated for females aged 9 to 26 to prevent cervical cancer and genital warts.
Pregnancy and breastfeeding
Can be given while breastfeeding